NACDS Hails Governor Brian Kemp, Georgia Lawmakers for Critical PBM Reform Legislation, HB 196
New law ushers in transparent pharmacy reimbursement for state health plans, fueling momentum for further progress in Georgia and nationwide.
New law ushers in transparent pharmacy reimbursement for state health plans, fueling momentum for further progress in Georgia and nationwide.
Long-overdue Medicaid PBM reforms would protect American taxpayers, patients, pharmacies
NACDS urges continued push for also-crucial reforms of PBM middleman tactics in Medicare
Association calls for phased, strategic action to strengthen U.S. pharmaceutical manufacturing while ensuring immediate safeguards for Americans’ access to necessary medications and trusted pharmacies.
Save Our Pharmacies Act Delivers New Transparency and Access for Virginia Medicaid Patients.
NACDS welcomes President Trump’s further scrutiny of PBM middlemen and intent to advance reforms as costs of inaction soar.
NACDS emphasizes the importance of enacting the sound reforms that are ready to go and broadly supported in the Congress.
NACDS calls for swift action on PBM reform legislation and implementation to safeguard Americans’ healthcare affordability and accessibility
NACDS touts pharmacies’ health and wellness innovation to confront the chronic disease crisis
Senators Peter Welch (D-VT), Roger Marshall (R-KS), Mark Warner (D-VA), and Bill Cassidy (R-LA) press for action on consensus reforms that would save $2 billion over ten years by confronting pharmaceutical benefit manipulation.
Nearly four pharmacies are closing every day; Americans are missing out on hundreds of millions in savings just since the last Congress’ end.
“By whatever means, the consensus PBM reforms are long overdue and need to be enacted now. The negative impacts of inaction are mounting for Americans and for their pharmacies.”
Pharmacy coalitions are urging Congress to enact immediate PBM reforms to address prescription drug costs and pharmacy closures, emphasizing the need for transparency, adequate reimbursement, and the elimination of harmful PBM practices.